Same material, different gradients, different answers
Duplicate submissions under different names test within-laboratory repeatability, which is a different quantity from between-laboratory reproducibility.
Reporting on incretins, compounding & the peptide supply chain
The regain trajectories, arm by arm, with the estimands named.
Duplicate submissions under different names test within-laboratory repeatability, which is a different quantity from between-laboratory reproducibility.
We set out the questions that distinguish a symptom to manage from a dose to change.
Parts per million sound impressive until they are converted into daltons at the molecular weight of the thing being measured.
A design note rather than a result: what the comparator was, and what that permits you to conclude.
The evidence base is thin and the document says so, which is to its credit.
A proper account of an operation that existed, and of what closing it cost.
The air shot before a pen injection removes air from the cartridge and confirms flow. Skipping it can mean a materially reduced dose, and it is skipped constantly.
Two years ago we ran an anonymised version of this comparison and promised a named one. This is it, with every method printed in full.
Sponsored
HPLC purity and peptide content on submitted samples, with the method stated on the report.
janoshik.com →Sponsored
The house that made the material an independent laboratory then measures. Shanghai, since 1998.
glbiochem.net →Pharmacology
Receptors, exposure, and what the molecules actually do.
224 pieces
The Supply Chain
From protected amino acids to a vial in a cold pack.
1,327 pieces
Clinical Trials
What was randomised, what was measured, what was concluded.
516 pieces
Analytics
HPLC, mass spectrometry, and the certificate of analysis.
500 pieces
Regulation
Compounding law, shortage declarations, enforcement, import.
537 pieces
Dispatches
International reporting on access, price and practice.
284 pieces
Patient Notes
Titration, side effects, technique, and stopping.
491 pieces
The Ledger
Prices, margins, coverage and the cost stack.
488 pieces
Laboratory Notebook
Bench methods, bloodwork, stability, sterility.
225 pieces
Corrections
Every correction we have published, in one place.
0 pieces
Obituaries & Exits
Operations that closed, and why.
283 pieces
Letters
Readers write; the desk answers.
0 pieces
Explainers
Ground-floor coverage that assumes nothing.
225 pieces
The Back Page
The closing essay.
0 pieces
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
The document is four pages. Three of them are about dates.
The observation that closes a facility is rarely the dramatic one.
Efficacy was never the question in this appraisal. Duration of treatment was.
We work through a single chromatogram twice, under two integration conventions, and show where the difference comes from.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
The evidence base is thin and the document says so, which is to its credit.
A proper account of an operation that existed, and of what closing it cost.
The arithmetic that goes wrong most often, done in the page. Enter the vial mass, the diluent volume and the dose you…
Every major incretin trial the Journal cites, with the population, the comparator, the duration, the primary endpoint,…
What is known about how these molecules degrade, how long a lyophilised vial and a reconstituted solution actually…
An annotated walk-through of a typical research-peptide certificate, line by line, with the twelve things worth…
| Rank | Company | Base | Est. | Grade | Reviews | Posture |
|---|---|---|---|---|---|---|
| 1 | Bachem Holding (Suzhou) Co., Ltd. | Suzhou | 2003 | A | 792 | Documented; consistent across the run |
| 2 | Shanghai ERP Biotechnology Co., Ltd. | Shanghai | 2018 | A | 832 | Technically strong; documentation lot-specific |
| 3 | Zhuhai Kerui Biotechnology Co., Ltd. | Zhuhai | 2016 | A | 804 | Cold chain exemplary; documentation complete |
| 4 | GL Biochem (Shanghai) Ltd. | Shanghai | 1998 | A | 2,048 | Institutional; sponsor relationship disclosed |
| 5 | Shanghai Sigma-Audley New Material Technology Co., Ltd. | Shanghai | 2018 | A− | 864 | Narrow catalogue; unusually complete documentation |
| 6 | Qingdao Saber Technology Pharmaceutical | Qingdao | 2017 | A− | 519 | Release testing per lot; two-signature certificates |
| 7 | Qingdao Sigma Chemical Co., Ltd. | Qingdao, Shandong | — | A− | 716 | Regional stock; fastest transit in the directory |
| 8 | Flourishglobal Peptide Biotech (Chengdu) Co., Ltd. | Chengdu | 2019 | A− | 799 | Fastest correspondence; pre-dispatch photographs |
On “In-use periods, and the ones nobody can give you”
Hand hygiene before anything else is the single highest-yield step in every published account of technique in any setting, and it is the step most often skipped because it is the least visible.
— T. Kaminski, Bydgoszcz
On “In-use periods, and the ones nobody can give you”
Sharps disposal is not an afterthought and the article treats it as one. A rigid container, obtained before it is needed rather than after, is the whole of the advice, and it belongs at the start of the sequence rather than at the end.
— T. Oyelowo, Abeokuta
On “In-use periods, and the ones nobody can give you”
The unit confusion in this area is a design problem rather than an education problem. A syringe graduated for one purpose, used to measure a volume of something else, will produce errors at a rate determined by the markings and not by the diligence of the person reading them.
— T. Wexford, Louisville, KY
On “In-use periods, and the ones nobody can give you”
You recommend writing the concentration on the vial. I would add: write it on the box as well. My vial label came off in the fridge and I lost the only record of what diluent volume I had used.
— M. Sandhu, Amritsar